DOP2006000268A - ANTIBACTERIAL AGENTS - Google Patents

ANTIBACTERIAL AGENTS

Info

Publication number
DOP2006000268A
DOP2006000268A DO2006000268A DO2006000268A DOP2006000268A DO P2006000268 A DOP2006000268 A DO P2006000268A DO 2006000268 A DO2006000268 A DO 2006000268A DO 2006000268 A DO2006000268 A DO 2006000268A DO P2006000268 A DOP2006000268 A DO P2006000268A
Authority
DO
Dominican Republic
Prior art keywords
compounds
antibacterial agents
methods
antibacterial
preparing
Prior art date
Application number
DO2006000268A
Other languages
Spanish (es)
Inventor
Timothy Allen Johnson
Debra Ann Sherry
Dennis Joseph Mcnamara
Peter Laurence Toogood
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37872452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DOP2006000268(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of DOP2006000268A publication Critical patent/DOP2006000268A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

En la presente memoria se describen compuestos antibacterianos, métodos para preparar los compuestos, composiciones farmacéuticas que contienen los compuestos y métodos para tratar infecciones bacterianas utilizando los compuestos y la composición farmacéutica.Antibacterial compounds, methods for preparing the compounds, pharmaceutical compositions containing the compounds and methods for treating bacterial infections using the compounds and the pharmaceutical composition are described herein.

DO2006000268A 2005-12-22 2006-11-29 ANTIBACTERIAL AGENTS DOP2006000268A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75326205P 2005-12-22 2005-12-22

Publications (1)

Publication Number Publication Date
DOP2006000268A true DOP2006000268A (en) 2007-07-31

Family

ID=37872452

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2006000268A DOP2006000268A (en) 2005-12-22 2006-11-29 ANTIBACTERIAL AGENTS

Country Status (12)

Country Link
US (2) US7557100B2 (en)
EP (2) EP2620439A1 (en)
JP (1) JP5513743B2 (en)
AR (1) AR058701A1 (en)
CA (1) CA2634644A1 (en)
DO (1) DOP2006000268A (en)
GT (1) GT200600520A (en)
NL (1) NL2000373C2 (en)
PE (1) PE20071137A1 (en)
TW (1) TW200734344A (en)
UY (1) UY30030A1 (en)
WO (1) WO2007072151A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3738591A3 (en) 2003-03-10 2021-03-24 Merck Sharp & Dohme Corp. Novel antibacterial agents
DOP2006000268A (en) * 2005-12-22 2007-07-31 Pfizer Prod Inc ANTIBACTERIAL AGENTS
MX2010000130A (en) * 2007-07-02 2010-03-18 Astrazeneca Ab 3-spiropyrimidinetrione-quinoline derivatives and their use as antibacterial agents.
ES2376200T3 (en) * 2007-07-06 2012-03-09 Aarhus Universitet NANOPART�? DEHYDRATED CULAS OF QUITOSANO.
AU2008277374A1 (en) 2007-07-16 2009-01-22 Astrazeneca Ab Spiro condensed barbituric acid derivatives for use as antibacterial
JP5698979B2 (en) 2007-10-25 2015-04-08 センプラ ファーマシューティカルズ，インコーポレイテッド Process for preparing macrolide antibacterial agents
EP2350077B1 (en) * 2008-10-14 2016-01-27 Entasis Therapeutics Limited Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
US9040528B2 (en) 2008-10-14 2015-05-26 Astrazeneca Ab Chemical compounds 542
EP3031460A1 (en) * 2008-10-24 2016-06-15 Cempra Pharmaceuticals Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
AU2010292010B2 (en) 2009-09-10 2016-01-07 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
US8975386B2 (en) 2010-03-22 2015-03-10 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
US9051346B2 (en) 2010-05-20 2015-06-09 Cempra Pharmaceuticals, Inc. Process for preparing triazole-containing ketolide antibiotics
KR20180110181A (en) 2010-09-10 2018-10-08 셈프라 파마슈티컬스, 인크. Hydrogen bond forming fluoro ketolides for treating diseases
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
US8952149B2 (en) 2012-09-26 2015-02-10 Zoetis Llc Tricyclic tetrahydroquinoline antibacterial agents
US8889671B2 (en) 2013-01-23 2014-11-18 Astrazeneca Ab Compounds and methods for treating bacterial infections
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
KR20170007818A (en) 2014-05-29 2017-01-20 엔타시스 테라퓨틱스 리미티드 Fusedspirocyclic heteroaromatic compounds for the treatment of bacterial infections
UY36851A (en) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd COMPOUNDS FOR USE IN ANTIBACTERIAL APPLICATIONS
WO2019023468A1 (en) 2017-07-28 2019-01-31 Nimbus Lakshmi, Inc. Tyk2 inhibitors and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011860A (en) 1986-04-11 1991-04-30 Schering Corporation Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases
DE19502178A1 (en) 1994-01-27 1995-08-03 Hoechst Ag Novel 1,3,4-thiadiazole(s) useful as liq. crystal intermediates
US6608081B2 (en) * 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
BR0114913A (en) 2000-10-26 2003-07-01 Pfizer Prod Inc Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
ATE315038T1 (en) * 2001-05-30 2006-02-15 Warner Lambert Co ANTIBACTERIAL AGENTS
AU2003228701A1 (en) 2002-04-25 2003-11-10 Bristol-Myers Squibb Company Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases
US7208490B2 (en) 2002-10-07 2007-04-24 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
JP2008543739A (en) 2005-05-09 2008-12-04 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Antibacterial agent
DOP2006000268A (en) * 2005-12-22 2007-07-31 Pfizer Prod Inc ANTIBACTERIAL AGENTS

Also Published As

Publication number Publication date
WO2007072151A1 (en) 2007-06-28
CA2634644A1 (en) 2007-06-28
EP2620439A1 (en) 2013-07-31
US20070197518A1 (en) 2007-08-23
UY30030A1 (en) 2007-07-31
NL2000373A1 (en) 2007-06-26
JP2009520804A (en) 2009-05-28
EP1971612A1 (en) 2008-09-24
AR058701A1 (en) 2008-02-20
PE20071137A1 (en) 2008-01-10
US7557100B2 (en) 2009-07-07
US20090275536A1 (en) 2009-11-05
JP5513743B2 (en) 2014-06-04
TW200734344A (en) 2007-09-16
NL2000373C2 (en) 2010-02-02
GT200600520A (en) 2007-07-17

Similar Documents

Publication Publication Date Title
DOP2006000268A (en) ANTIBACTERIAL AGENTS
UY30759A1 (en) CHEMICAL COMPOUNDS
CY1109916T1 (en) Benzimidazolo-thiophene compounds as PLK inhibitors
BRPI0810064B8 (en) compounds containing tricyclic nitrogen as antibacterial agents, pharmaceutical compositions comprising said compounds and their use for the treatment of bacterial infections in mammals
UY31673A1 (en) "UREA HETEROCYCLIC DERIVATIVES AND METHODS OF USE OF THE SAME-211"
CO6321189A2 (en) BENCEN-SULFONAMIDE TIAZOL AND OXAZOL COMPOUNDS
NO20082191L (en) Connections
CL2007002100A1 (en) BICYCLE DERIVATIVE COMPOUNDS CONTAINING NITROGEN, ITS SALTS, SOLVATES AND N-OXIDES; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF BACTERIAL INFECTIONS.
EA033311B1 (en) Benzoxaborole derivatives as antibacterial agents
UY32158A (en) HETEROCICLIC DERIVATIVES AND METHODS OF USE OF THE SAME
DOP2010000304A (en) COMPOSITIONS AND METHODS OF PREPARATION AND USE OF THE SAME
EA200901617A1 (en) SMALL SIZE BORCEDATION MOLECULES
WO2006120563A3 (en) Antibacterial agents
CL2011000691A1 (en) Compounds derived from substituted nicotinamide; pharmaceutical composition that includes them; use for the treatment and / or prevention of cancer, infections, inflammatory and autoimmune diseases.
CL2008002295A1 (en) Alkylsulfonyl-substituted thiazolid derivative compounds; pharmaceutical composition; and use for the treatment of hepatitis c.
UY29767A1 (en) BENZOTIAZOLONAS DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
DE602004021644D1 (en) GYRASEINHIBITORS AND THEIR USES
CL2008002430A1 (en) Benzenesulfonamide derived compounds, cathepsin c inhibitors; pharmaceutical composition comprising them; and its use for the treatment of copd.
ATE459620T1 (en) BENZIMIDAZOLETHIOPHENE COMPOUNDS AS PLK MODULATORS
UY30544A1 (en) PIRROLO-PIPERIDINE COMPOUNDS AND PHARMACEUTICAL SALTS ACCEPTABLE OF THE SAME, MANUFACTURING PROCESSES, COMPOSITIONS AND APPLICATIONS
NO20062705L (en) Antimicrobial composition useful for wood impregnation
PA8855001A1 (en) MONOCARBAMAS
GT201000047A (en) IMPROVEMENTS IN ORGANIC COMPOUNDS OR RELATED TO THE SAME
CL2008000202A1 (en) Compounds derived from n-aryl-acetamide, trpv1 antagonist, pharmaceutical composition that comprises them, useful in the treatment of pain.
EA200801414A1 (en) CALCYLYTIC COMPOUNDS